This session will provide insights on the potential of whole genome sequencing (WGS) in rare disease diagnostics. It will provide actionable insights into leveraging WGS to uncover elusive diagnoses while highlighting emerging technologies shaping the future of rare disease care. 

Topics include:

• Move beyond the genome in the Undiagnosed Disease Network with the GREGoR program
• How to use long-read sequencing as an emergent technology in clinical settings including rare disease

Speakers
Akash Kumar, MD, PhD, Chief Medical and Scientific Officer, MyOme
Danny Miller, MD, PhD, FACMG, Assistant Professor, University of Washington
Stephen Montgomery, PhD, Professor, Stanford University